MBIO
NASDAQ
$0.65
Mustang Bio Inc (MBIO)
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, is focused on translating medical advances in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. The company is headquartered in Worcester, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Target: $10 (+1433.74%)
Market Cap
$4.25M
P/B Ratio
0.60
Beta (5Y)
-0.03
Price Chart
Valuation
Market Cap$4.25M
P/S2205.73
P/B0.60
Profitability
EBITDA-$3.24M
EPS-$0.46
Growth & Risk
FCF 5Y CAGR-34.09%
Beta (5Y)-0.03
Sharpe Ratio-1.51